Liabilities of EVOME MEDICAL TECHNOLOGIES INC. from 28 Feb 2021 to 31 Dec 2023

Taxonomy & unit
us-gaap: CAD
Description
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
Summary
EVOME MEDICAL TECHNOLOGIES INC. quarterly Liabilities in CAD history and change rate from 28 Feb 2021 to 31 Dec 2023.
  • EVOME MEDICAL TECHNOLOGIES INC. Liabilities for the quarter ending 31 Dec 2023 was CA$44,254,081, a 21% increase year-over-year.
Source SEC data
View on sec.gov
Liabilities, Quarterly (CAD)
Liabilities, YoY Quarterly Change (%)

EVOME MEDICAL TECHNOLOGIES INC. Quarterly Liabilities (CAD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2023 CA$44,254,081 +CA$7,535,366 +21% 31 Dec 2023 10-K 16 Apr 2024 2023 FY
Q3 2023 CA$48,496,975 +CA$16,619,068 +52% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 CA$54,342,319 +CA$33,617,922 +162% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 CA$38,943,053 +CA$9,414,604 +32% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 CA$36,718,715 +CA$1,936,867 +5.6% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q3 2022 CA$31,877,907 +CA$8,272,224 +35% 31 Aug 2022 10-Q 17 Oct 2022 2022 Q2
Q2 2022 CA$20,724,397 -CA$3,078,636 -13% 31 May 2022 10-Q 15 Jul 2022 2023 Q1
Q1 2022 CA$29,528,449 +CA$23,040,291 +355% 28 Feb 2022 10-KT 03 Apr 2023 2022 FY
Q4 2021 CA$34,781,848 31 Dec 2021 10-KT 03 Apr 2023 2022 FY
Q3 2021 CA$23,605,683 31 Aug 2021 10-Q 15 Oct 2021 2022 Q2
Q2 2021 CA$23,803,033 31 May 2021 10-Q/A 02 Aug 2021 2022 Q1
Q1 2021 CA$6,488,158 28 Feb 2021 10-K 31 May 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.